STOCK TITAN

Intercontinental Exchange (NYSE: ICE) counsel sells thousands of shares under preset trading plan

(Very High)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Intercontinental Exchange, Inc. (ICE) reported that General Counsel Andrew J. Surdykowski exercised 2,065 stock options at an exercise price of $57.31 per share, converting them into an equal number of ICE common shares. On the same day, he sold an aggregate of 4,574 common shares in open-market transactions at prices ranging from $161.16 to $162.95, all pursuant to a Rule 10b5-1 trading plan that became effective November 25, 2025. The options exercised were fully vested, and a remaining option balance of 2,064 options is reported. Beneficial holdings also include 35,891 shares of common stock, 5,734 unvested RSUs, and 1,440 performance-based RSUs whose satisfaction and share issuance will be determined in future periods.

Positive

  • None.

Negative

  • None.

Insights

Analyzing...

Insider Surdykowski Andrew J
Role General Counsel
Sold 4,574 shs ($740K)
Approx. gross sale proceeds $740K
Approx. exercise cost $118K
Type Security Shares Price Value
Exercise Employee Stock Option (right to buy) Holding F8 2,065 $0.00 $0.00
Exercise Common Stock F1, F2 2,065 $57.31 $118K
Sale Common Stock F1, F3 3,974 $161.6737 $642K
Sale Common Stock F1, F4, F5, F6, F7 600 $162.3833 $97K
Holdings After Transaction: Employee Stock Option (right to buy) Holding — 2,064 shares (Direct); Common Stock — 43,065 shares (Direct)
Footnotes (8)
  1. F1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
  2. F2. Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
  3. F3. The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  4. F4. The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
  5. F5. The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
  6. F6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
  7. F7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
  8. F8. These options are fully vested.
Options exercised 2,065 shares Employee Stock Option exercise on August 26, 2026
Option exercise price $57.31 per share Exercise price for 2,065 employee stock options
Shares sold (first sale) 3,974 shares at $161.6737 per share Open-market sale of ICE common stock on August 26, 2026
Price range (first sale block) $161.16–$162.14 per share Footnote-disclosed price range for 3,974-share sale
Shares sold (second sale) 600 shares at $162.3833 per share Additional open-market sale on August 26, 2026
Price range (second sale block) $162.16–$162.95 per share Footnote-disclosed price range for 600-share sale
Beneficial common shares 35,891 shares Part of aggregate beneficial ownership of ICE equity
Unvested RSUs and PSUs 5,734 RSUs and 1,440 PSUs Unvested and performance-based ICE equity awards held
Rule 10b5-1 trading plan regulatory
"This transaction was effected pursuant to a Rule 10b5-1 trading plan..."
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
Employee Stock Option financial
"Employee Stock Option (right to buy) Holding"
An employee stock option is a promise that lets a worker buy company shares later at a predetermined price, often after they stay for a certain period or meet performance goals — think of it like a coupon that locks in today's price for a future purchase. It matters to investors because options align employees’ incentives with company performance, can increase the number of shares outstanding (dilution) when exercised, and represent a compensation cost that affects reported profits and shareholder value.
restricted stock units ("RSUs") financial
"represents 35,891 shares of common stock and 5,734 unvested restricted stock units"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
performance based restricted stock units ("PSUs") financial
"and 1,440 performance based restricted stock units ("PSUs"), for which the"
earnings before interest, taxes, depreciation, and amortization ("EBITDA") financial
"three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs"
Earnings before interest, taxes, depreciation, and amortization (EBITDA) is a measure of a company's operating profitability that strips out financing costs, tax effects, and certain accounting write‑downs to focus on core business performance. For investors it offers a quick way to compare how efficiently different companies generate earnings from their operations—like comparing the cash-making engine of two shops while ignoring their different loan payments, tax situations, or bookkeeping choices—though it doesn’t replace detailed cash‑flow or profit analysis.
Deal Incentive Awards financial
"performance based restricted stock units granted as Deal Incentive Awards and"

FAQ

What insider transactions did ICE General Counsel Andrew J. Surdykowski report on this Form 4 for ICE?

He exercised 2,065 stock options at an exercise price of $57.31 per share, acquiring the same number of ICE common shares, and sold a total of 4,574 common shares in open-market transactions on August 26, 2026.

At what prices did Andrew J. Surdykowski sell ICE stock in this Form 4?

He sold 3,974 shares of ICE common stock at an average price of $161.6737 per share, with a price range of $161.16–$162.14, and 600 shares at an average price of $162.3833, with a price range of $162.16–$162.95.

Were Andrew J. Surdykowski’s ICE stock sales under a Rule 10b5-1 plan?

Yes. The filing states the transactions were effected pursuant to a Rule 10b5-1 trading plan that was approved and became effective on November 25, 2025.

What option exercise did Andrew J. Surdykowski report for ICE on this Form 4?

He exercised 2,065 employee stock options with an exercise price of $57.31 per share, converting them into 2,065 shares of ICE common stock. The options are reported as fully vested and expire on January 18, 2027.

What ICE equity awards and holdings are reported for Andrew J. Surdykowski in this Form 4?

Beneficial ownership includes 35,891 common shares, 5,734 unvested RSUs, and 1,440 performance-based RSUs (PSUs), plus additional TSR and EBITDA PSUs and Deal Incentive Awards whose ultimate share issuance will be determined between December 2026 and February 2029.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Surdykowski Andrew J

(Last)(First)(Middle)
5660 NEW NORTHSIDE DRIVE

(Street)
ATLANTA GEORGIA 30328

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Intercontinental Exchange, Inc. [ ICE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/26/2026M2,065(1)A$57.3147,639(2)D
Common Stock08/26/2026S3,974(1)D$161.6737(3)43,665D
Common Stock08/26/2026S600(1)D$162.3833(4)43,065(5)(6)(7)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Stock Option (right to buy) Holding$57.3108/26/2026M2,065 (8)01/18/2027Common Stock2,065$02,064D
Explanation of Responses:
1. This transaction was effected pursuant to a Rule 10b5-1 trading plan which was approved and became effective as of November 25, 2025.
2. Amount of securities beneficially owned includes 101 shares acquired under Intercontinental Exchange, Inc. Employee Stock Purchase Plan on June 30, 2026.
3. The price range for the aggregate amount sold by the direct holder is $161.16 - $162.14. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
4. The price range for the aggregate amount sold by the direct holder is $162.16 - $162.95. The Issuer will upon request by the Staff of the U.S. Securities and Exchange Commission or a security holder of the Issuer provide the full information regarding the number of shares sold at each separate price.
5. The common stock number referred in Table I is an aggregate number and represents 35,891 shares of common stock and 5,734 unvested restricted stock units ("RSUs"), and 1,440 performance based restricted stock units ("PSUs"), for which the performance period has been satisfied. The RSUs and PSUs vest over a three-year period, in which 33.33% of the units vest each year.
6. The satisfaction of the 2024, 2025 and 2026 TSR PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting. The satisfaction of the 2024, 2025 and 2026 three-year earnings before interest, taxes, depreciation, and amortization ("EBITDA") PSUs and the corresponding number of shares to be issued pursuant to these awards, will not be determined until February 2027, February 2028 and February 2029, respectively, and will be reported at the time of vesting.
7. The satisfaction of the performance based restricted stock units granted as Deal Incentive Awards and the corresponding number of shares to be issued pursuant to these awards, will not be determined until December 2026, December 2027 and December 2028 and will be subject to additional time-based vesting conditions and, if applicable, a subsequent one-year holding period.
8. These options are fully vested.
/s/ Octavia N. Spencer, Attorney-in-fact08/28/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)